What are the causes of nephrocalcinosis?

Causes of Nephrocalcinosis

Nephrocalcinosis results from calcium salt deposition in renal parenchyma due to hypercalciuria, hypercalcemia, metabolic disorders, hereditary tubulopathies, and iatrogenic factors, with the specific etiology varying significantly by age and clinical context.

Hereditary Tubular Disorders

The most common genetic causes involve inherited renal tubulopathies that disrupt calcium handling:

• Distal renal tubular acidosis is a leading hereditary cause of medullary nephrocalcinosis in children, characterized by impaired urinary acidification and hypercalciuria 1, 2
• Dent disease represents another major hereditary tubulopathy causing nephrocalcinosis, with limited supportive therapies and often necessitating early renal replacement 1, 2
• Bartter syndrome causes nephrocalcinosis through hypercalciuria secondary to impaired salt reabsorption in the thick ascending limb, particularly in types 1-3 3
• X-linked hypophosphatemia (XLH) causes nephrocalcinosis in 30-70% of patients, primarily related to treatment with phosphate supplementation and active vitamin D 3

Metabolic Disorders

Systemic metabolic abnormalities frequently precipitate calcium deposition:

• Idiopathic hypercalciuria is among the most common metabolic causes in children 1
• Primary hyperoxaluria (particularly type 1) leads to calcium oxalate deposition, early-onset nephrocalcinosis, and progression to chronic kidney disease; this diagnosis must always be investigated in young children with nephrocalcinosis 3, 1, 4
• Hypercalcemia from various causes including primary hyperparathyroidism drives calcium salt precipitation 5, 6
• Williams syndrome causes increased intestinal calcium absorption and persistent hypercalcemia, leading to nephrocalcinosis in affected children 3

Iatrogenic and Treatment-Related Causes

Medical interventions represent a substantial proportion of nephrocalcinosis cases:

• Furosemide administration in premature infants with chronic lung disease causes phosphaturia and magnesium depletion, increasing calcium excretion and nephrocalcinosis risk 3
• Vitamin D intoxication or excessive supplementation promotes hypercalciuria and calcium deposition 1
• Phosphate and active vitamin D therapy for XLH increases calciuria in a dose-dependent manner, with positive associations between daily oral phosphate doses and nephrocalcinosis development 3
• Large doses of active vitamin D (calcitriol or alfacalcidol) promote growth but carry increased risk of hypercalciuria and nephrocalcinosis 3

Prematurity-Related Nephrocalcinosis

Preterm infants face unique multifactorial risks:

• Extreme prematurity with underdeveloped renal function represents the most important variable, as hypercalciuria is common in very low birth weight infants 3
• Decreased glomerular filtration rate, low citrate excretion, and alkaline urine due to renal immaturity contribute to calcium precipitation 3
• Chronic lung disease of infancy (CLDI) requiring diuretic therapy substantially increases nephrocalcinosis risk in premature infants 3
• The incidence has increased in preterm populations, with multifactorial iatrogenic origins predominating 1, 7

Age-Specific Considerations

The etiology differs markedly by gestational age and developmental stage:

• Full-term children show higher rates of persistent nephrocalcinosis, chronic kidney disease, and underlying monogenic mutations (OR 10.02) compared to preterm infants 7
• Children presenting before age 8 years (particularly those with PH1 presenting at median age 3 years) warrant investigation for hereditary causes 4
• Preterm infants more commonly have iatrogenic causes related to bronchopulmonary dysplasia management, patent ductus arteriosus treatment, and furosemide/vitamin D use 7

Clinical Pitfalls and Prevention Strategies

Critical management considerations to prevent nephrocalcinosis:

• Monitor urinary calcium excretion closely in patients receiving phosphate supplements and active vitamin D, keeping levels within normal range to prevent nephrocalcinosis 3
• Avoid phosphate doses exceeding 80 mg/kg daily (elemental phosphorus) in XLH patients, as higher doses show positive associations with nephrocalcinosis development 3
• Implement preventive measures including regular water intake, potassium citrate administration (with caution in XLH due to alkalinization risks), and limited sodium intake in patients with hypercalciuria 3
• Consider hydrochlorothiazide to decrease calciuria in XLH patients at risk 3
• Perform genetic testing in full-term children with nephrocalcinosis lacking obvious clinical risk factors, as monogenic causes are significantly more prevalent in this population 7

Distinguishing Features for Diagnosis

Key characteristics that differentiate underlying etiologies:

• Nephrocalcinosis with decreased eGFR at diagnosis (median 52 mL/min/1.73 m²), presentation before adolescence, and 100% calcium oxalate monohydrate stone composition strongly suggest PH1 4
• Medullary nephrocalcinosis most commonly indicates hereditary tubular disorders, metabolic causes, or iatrogenic factors 1
• Cortical or diffuse nephrocalcinosis requires broader differential consideration including systemic metabolic disorders 1